PNW vs STRO · P/E 19, rev $5.12B vs rev $62.0M
Pinnacle West Capital Corp (PNW) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Pinnacle West Capital Corp (PNW) is a utilities - regulated electric company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported PNW revenue for 2024-12-31 was $5.12B. Net income was $626.0M. Revenue was up 9.1% from 2023-12-31 to 2024-12-31. PNW currently screens at market cap $12.41B and trailing P/E 19.1.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
PNW currently screens at market cap $12.41B and trailing P/E 19.1. STRO currently screens at market cap $470.8M.
Not investment advice. Open the PNW and STRO stock pages for the full models.
Not investment advice.